share_log

BRIEF-Oncolytics Biotech Reports Preclinical Data Demonstrating Synergistic Anti-Cancer Activity Of Pelareorep Combined With Car T Cell Therapy In Solid Tumors

BRIEF-Oncolytics Biotech Reports Preclinical Data Demonstrating Synergistic Anti-Cancer Activity Of Pelareorep Combined With Car T Cell Therapy In Solid Tumors

Brief-Oncollytics Biotech报告临床前数据显示Pareorep联合CAR T细胞治疗实体瘤具有协同抗癌活性
Reuters ·  2021/02/23 20:23

Feb 23 (Reuters) - Oncolytics Biotech Inc ONC.TO :

路透2月23日电-Oncolytics Biotech Inc.ONC.TO:

* ONCOLYTICS BIOTECH REPORTS PRECLINICAL DATA DEMONSTRATING SYNERGISTIC ANTI-CANCER ACTIVITY OF PELAREOREP COMBINED WITH CAR T CELL THERAPY IN SOLID TUMORS

*Oncolytics生物技术报告临床前数据显示,Pelareorep联合CAR T细胞治疗在实体瘤中具有协同抗癌活性

* ONCOLYTICS BIOTECH INC - MAYO CLINIC SHOWS PELAREOREP VASTLY IMPROVED PERSISTENCE AND EFFICACY OF CAR T CELL THERAPY LEADING TO CURES IN MODEL

*Oncolytics Biotech Inc-Mayo诊所显示,Pelareorep极大地提高了CAR T细胞治疗的持久性和有效性,从而治愈了In模型

* ONCOLYTICS BIOTECH INC - PELAREOREP&aposS SYNERGISTIC EFFECTS WITH CAR T THERAPY APPEAR TO BE SPECIFIC AND WERE NOT OBSERVED WITH ONCOLYTIC VIRUS VSV

*Oncolytics Biotech Inc-pelareorep&aposS与CAR T治疗的协同效应似乎是特异的,在溶瘤病毒VSV中没有观察到

* ONCOLYTICS BIOTECH INC - RESULTS DEMONSTRATE POTENTIAL OF PELAREOREP TO BROADEN APPLICABILITY OF CAR T CELLS TO SOLID TUMORS

*Oncolytics Biotech Inc-结果表明,Pelareorep有潜力扩大CAR T细胞对实体肿瘤的适用性

Source text for Eikon: Further company coverage:

Eikon的源文本:进一步的公司报道:

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发